Key result
A 17-year-old male with COVID-19 vaccine-associated myocarditis developed a 3-beat run of nonsustained ventricular tachycardia at 230 bpm during an exercise stress test 6 months after diagnosis.
Why the study?
The long-term outcomes of COVID-19 vaccine-associated myocarditis are unclear.
Follow-up
over 6 months
Authors
Loading...
NSVT at 6 months after vaccine myocarditis warrants extended arrhythmia surveillance in adolescents; leaves open long-term risk and monitoring needs.
Case Report (n=1)
Highlights the potential for late ventricular arrhythmias in patients with a history of COVID-19 vaccine-associated myocarditis, suggesting a need for careful follow-up.
Sheth et al. (2023) conducted a case report in COVID-19 vaccine-associated myocarditis (n=1). COVID-19 vaccine was evaluated on Nonsustained ventricular tachycardia. A 17-year-old male with COVID-19 vaccine-associated myocarditis developed a 3-beat run of nonsustained ventricular tachycardia at 230 bpm during an exercise stress test 6 months after diagnosis.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: